Premenstrual Symptoms and Aromatherapy
Effect of Neroli and Lemongrass Oils With Premenstrual Symptoms and Effect on Quality of Life: Randomized Controlled Research
1 other identifier
interventional
120
1 country
1
Brief Summary
Aromatherapy is the science of using high concentrated essential oils or essences with distilled high concentration of plants to take advantage of therapeutic properties '' . Essential oils or essences are obtained from various parts of plants (root, leaf, flower, shell, fruit) and therapeutically used for physical and psychological favors. The aromatherapine is a noninvasive process and the convenience of use allows the widespread use of aromatherapy. Aromatic oils can be applied in four basic ways. These are topical (tap, compressed or bath), internal (mouthwash, vaginal or anal wick), mouth (with capsules or honey, alcohol or diluent) and inhalation (inhalation directly or indirectly, steam or vapor ) is the way . Volatile oils that can be applied in various means can reach the neocortex part of the brain directly with the links to the hypothalamus from the limbic system. As a result of the impact of aromatic oils on the central nervous system, relief, sedation or stimulating effects are formed and the energy blockage in the body is broken, due to the information stream reaching the brain with the warning of the central nervous system and the resulting energy is exposed. The improvement process is supported by its exposed energy stream in a balanced way of the relevant organs, and the state of physical and spiritual goodness is emerged. Aromatherapy is also used in the field of women's health as well as many health areas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 31, 2022
CompletedStudy Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedOctober 26, 2023
December 1, 2022
2 months
April 26, 2022
October 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Personal Information Form
A questionnaire with 12 questions was created by the researchers. The filling time of the participants is 5-6 minutes.
1 year
Premenstrual Syndrome Scale
Participants in the study will be asked to fill in this scale in the pre-test. Women with premenstrual syndrome will be included in the study.The application of the premenstrual syndrome scale is made by evaluating the person retrospectively, taking into account the "being in the period one week before the period". The total score is obtained from the sum of the scores from all sub-dimensions. A minimum of 44 and a maximum of 220 points can be obtained from the scale. An increase in the score obtained from the scale indicates an increase in the intensity of the symptoms. If the total scale score (220) exceeds 50% (110) in the PMS scale, PMS is considered as "present".
1 year
Secondary Outcomes (2)
Scale for Coping With Premenstrual Symptoms
1 year
SF-36 Quality of Life Scale
1 year
Study Arms (2)
Neroli oil
EXPERIMENTALNeroli oil improves the quality of life by reducing premenstrual symptoms with relaxing and calming effect.
Lemongrass oil
EXPERIMENTALLemongrass oil improves the quality of life by reducing premenstrual symptoms with relaxing and calming effect.
Interventions
6 drops of aromatic oils used by the researcher will be dripped by the aromatic oils to take the fragrance by inhalation for 30 minutes.
Eligibility Criteria
You may qualify if:
- Premenstrual is at least 5 of the complaints living (self-notice),
- Non-respiratory disease such as asthma, bronchitis (self-notice),
- Not allergic to fat to be used (self-notice),
- Pregnancy or pregnancy doubt (self-notice),
- Diabetes, hypertension without a systemic discomfort (self-notice)
You may not qualify if:
- Premenstrual has not experienced complaints,
- Using cigarettes or alcohol,
- With chronic discomfort (respiratory diseases),
- Pregnancy suspected or conceived,
- With a systemic discomfort such as diabetes, hypertension,
- Individuals who do not want to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
KTO Karatay University
Konya, 42000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Füsun SUNAR, Associate Professor
Kto Karatay Üniversitesi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- In the study, the evaluation and statistical analysis will be blinded. Statistical analyzes will be carried out by a faculty member other than researchers. A non-aware of the experiment and control groups will be aware of the assessment of initiatives. Data entries will be entered with "A", "B" and "C" code without the test or control group specified. Writing the analysis and research report of the data will be carried out to be coded as "A", "B" and "C" group. After the statistical analysis is made and the research report is written, the encoders for the experiment and the control group will be explained by the encoder by the encoder. The data collection tool described below before the venture and the control group will be applied below
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2022
First Posted
October 31, 2022
Study Start
December 15, 2023
Primary Completion
January 30, 2024
Study Completion
July 30, 2024
Last Updated
October 26, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share